In this target trial emulation study, denosumab was found to increase the risk of hypocalcemia requiring emergency treatment ...

Medically reviewed by Robert Burakoff, MD Celiac disease is a chronic autoimmune disorder that can damage the lining of your ...

Osteoporosis, a disease that weakens your bones, is also called a “silent” disease because there are no warning signs until a ...

OBODENCE™ and XBRYK™ recommended for approval by the European Medicines Agency for all indications referencing Prolia and Xgeva, respectively INCHEON, South Korea, Nov. 15, 2024 (GLOBE NEWSWIRE) -- ...

Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).

Lung transplant patients should undergo annual bone health screenings using dual-energy X-ray absorptiometry for the first ...

An international, Phase III clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare ...

Regular screenings, lifestyle modifications and open conversations with healthcare providers can pave the way for healthier ...

ATA 2024 spotlighted new research to help endocrinologists manage the subsequent fertility, bone health, and cardiovascular ...

Working out prior to menopause will reduce the risk of osteoporosis in your later years. And avoid harmful habits – smoking and heavy alcohol consumption can weaken bone density and increase the risk ...

The presentation highlights the potential benefits of eneboparatide as a treatment for hypoparathyroidism, an illness in ...

Calcium levels decreased less with each subsequent denosumab dose among individuals with osteoporosis and advanced chronic kidney disease.